Orion Infusion Limited

ORIONINFU

BD0472ORINF6

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 15/05/2024 BST			5-day change	1st Jan Change
634.1 ^BDT	+5.47%		+1.47%	+75.51%

02-07	Orion Infusion Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Orion Infusion Limited Recommends Cash Dividend for the Year Ended June 30, 2023	CI

Orion Infusion Limited Announces Earnings Results for the Year Ended on June 30, 2018

November 01, 2018 at 11:05 am

Orion Infusion Limited announced earnings results for the year ended on June 30, 2018. For the year, the company reported EPS of BDT 1.62 against BDT 1.53 a year ago.

Latest news about Orion Infusion Limited

Orion Infusion Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-07	CI
Orion Infusion Limited Recommends Cash Dividend for the Year Ended June 30, 2023	11-05	CI
Orion Infusion Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	29/10/23	CI
Orion Infusion Limited Announces Executive Changes	02/10/23	CI
Orion Infusion Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	02/05/23	CI
Orion Infusion Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	29/03/23	CI
Orion Infusion Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	27/11/22	CI
Orion Infusion Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	29/04/22	CI
Orion Infusion Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	06/02/22	CI
Orion Infusion Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	16/11/21	CI
Orion Infusion Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	04/07/21	CI
Orion Infusion Limited Recommends Cash Dividend for Year Ended on June 30, 2020	09/11/20	CI
Orion Infusion Limited Reports Earnings Results for the First Quarter Ended September 30, 2020	29/10/20	CI
Orion Infusion Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	29/04/20	CI
Orion Infusion Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	29/01/20	CI
Orion Infusion Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	15/11/19	CI
Orion Infusion Limited Recommends Cash Dividend for Year Ended on June 30, 2019	27/10/19	CI
Orion Infusion Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	06/05/19	CI
Orion Infusion Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018	02/02/19	CI
Orion Infusion Limited Recommends Cash Dividend for Year Ended on June 30, 2018	01/11/18	CI
Orion Infusion Limited Announces Earnings Results for the Year Ended on June 30, 2018	01/11/18	CI
Orion Infusion Limited Reports Earnings Results for the First Quarter Ended September 30, 2018	29/10/18	CI
Orion Infusion Limited Announces Un-Audited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	29/04/18	CI
Orion Infusion Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December, 2017	29/01/18	CI
Orion Infusion Limited Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2017	14/11/17	CI

Orion Infusion Limited is a Bangladesh-based large volume parenteral (LVP) manufacturing company. The Company is a provider of quality medicines and health care services through approximately 28 brands and 42 presentations of various formulations. The Company is engaged in manufacturing and marketing of Intravenous (I.V.) fluid, lifesaving intravenous medicine and intravascular saline, which include fluid and nutrient, fluid and electrolyte, fat emulsion for I.V. use, fluid, nutrient and electrolyte, plasma substitute, antiulcerant, osmotic diuretic and amino acid solutions. The Company has the manufacturing facilities for the production of I.V. Rehydration Solutions, Electrolyte Solutions, and Solution for Acidosis, Ranitidine I.V. infusion, Anti-Microbial products viz. Ciprofloxacin I.V., Metronidazole I.V. and others. The Company's production plant is situated at Maikuli, P.S. Rupganj, and District- Naraynganj, Bangladesh.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ORION INFUSION LIMITED	+75.51%	110M
ELI LILLY AND COMPANY	+32.36%	694B
NOVO NORDISK A/S	+29.69%	593B
JOHNSON & JOHNSON	-1.60%	371B
MERCK & CO., INC.	+20.07%	331B
ABBVIE INC.	+6.04%	290B
ASTRAZENECA PLC	+14.43%	239B
ROCHE HOLDING AG	-3.52%	209B
NOVARTIS AG	+10.13%	209B
AMGEN INC.	+9.27%	169B